Baidu
map

A&R:体重指数降低与膝关节骨性关节炎结构缺陷的发生率和进展降低相关:一项前瞻性多队列研究

2022-08-22 MedSci原创 MedSci原创

BMI降低与膝关节骨关节炎结构缺陷的发病和进展几率降低独立相关,并且可能是预防膝关节骨关节炎发病或恶化的一个组成部分。 

目的超重和肥胖是膝骨关节炎发病和进展的危险因素,近25%的新发膝关节疼痛或骨关节炎是由体重过重引起的。本研究目的在于定义体重指数(BMI)变化与通过放射照相评估的膝关节骨性关节炎结构缺陷的发生率和进展之间的关联。

方法:从以下三个独立的队列研究中获得基线和45年随访时膝关节的放射学分析:来自美国的骨关节炎倡议(OAI)研究和多中心骨关节炎研究(MOST),以及来自芬兰的队列髋关节和队列膝研究(CHECK)。使用广义估计方程进行逻辑回归分析,并以个人为单位对双膝进行聚类,用于研究BMI从基线到45年随访的变化与膝关节骨关节炎的发病率和进展之间的关联。

结果:研究了“发病队列”中来自5774名参与者的9683个膝盖和“进展队列”中来自3988名参与者的6075个膝盖(涵盖男性和女性患者)。纳入患者在基线时有/没有膝关节骨关节炎结构缺陷BMI的变化与膝骨关节炎结构缺陷的发生率和进展呈正相关。发病率的调整优势比为1.0595% 置信区间[CI] 1.021.09进展为1.0595% CI 1.011.09BMI的变化也与关节间隙的退化(即变窄)以及膝关节内侧的股骨和胫骨表面(如骨赘所示)的退化呈正相关,但与膝关节外侧无关。

结论BMI降低与膝关节骨关节炎结构缺陷的发病和进展几率降低独立相关,并且可能是预防膝关节骨关节炎发病或恶化的一个组成部分。 

原始出处:Salis Z, Gallego B, Nguyen TV, Sainsbury A. Decrease in body mass index is associated with reduced incidence and progression of the structural defects of knee osteoarthritis: a prospective multi-cohort study. Arthritis Rheumatol. 2022 Aug 16. doi: 10.1002/art.42307. Epub ahead of print. PMID: 35974435.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1826813, encodeId=e5e0182681321, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Nov 13 17:19:30 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006575, encodeId=4d1620065e58b, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Fri Apr 07 21:19:30 CST 2023, time=2023-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266530, encodeId=e610126653094, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422438, encodeId=85bc142243895, content=<a href='/topic/show?id=96a1858859d' target=_blank style='color:#2F92EE;'>#膝关节骨性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85885, encryptionId=96a1858859d, topicName=膝关节骨性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03183693475, createdName=changhe714, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1826813, encodeId=e5e0182681321, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Nov 13 17:19:30 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006575, encodeId=4d1620065e58b, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Fri Apr 07 21:19:30 CST 2023, time=2023-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266530, encodeId=e610126653094, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422438, encodeId=85bc142243895, content=<a href='/topic/show?id=96a1858859d' target=_blank style='color:#2F92EE;'>#膝关节骨性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85885, encryptionId=96a1858859d, topicName=膝关节骨性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03183693475, createdName=changhe714, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1826813, encodeId=e5e0182681321, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Nov 13 17:19:30 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006575, encodeId=4d1620065e58b, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Fri Apr 07 21:19:30 CST 2023, time=2023-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266530, encodeId=e610126653094, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422438, encodeId=85bc142243895, content=<a href='/topic/show?id=96a1858859d' target=_blank style='color:#2F92EE;'>#膝关节骨性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85885, encryptionId=96a1858859d, topicName=膝关节骨性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03183693475, createdName=changhe714, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=)]
    2022-08-21 lmm397
  4. [GetPortalCommentsPageByObjectIdResponse(id=1826813, encodeId=e5e0182681321, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Sun Nov 13 17:19:30 CST 2022, time=2022-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2006575, encodeId=4d1620065e58b, content=<a href='/topic/show?id=924a3264381' target=_blank style='color:#2F92EE;'>#前瞻性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32643, encryptionId=924a3264381, topicName=前瞻性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb32500112, createdName=1508842480_96220437, createdTime=Fri Apr 07 21:19:30 CST 2023, time=2023-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1266530, encodeId=e610126653094, content=<a href='/topic/show?id=57a53011364' target=_blank style='color:#2F92EE;'>#关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30113, encryptionId=57a53011364, topicName=关节炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f90281, createdName=lmm397, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422438, encodeId=85bc142243895, content=<a href='/topic/show?id=96a1858859d' target=_blank style='color:#2F92EE;'>#膝关节骨性关节炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85885, encryptionId=96a1858859d, topicName=膝关节骨性关节炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=03183693475, createdName=changhe714, createdTime=Sun Aug 21 10:19:30 CST 2022, time=2022-08-21, status=1, ipAttribution=)]

相关资讯

Stroke:动脉瘤性蛛网膜下腔出血后发病率和死亡率的预防

尼莫地平和西洛他唑可能是预防动脉瘤性蛛网膜下腔出血患者发病率和死亡率最有效的治疗方法。克拉森坦、尼卡地平、法舒地尔和镁对迟发性脑缺血和血管痉挛有积极作用,但未发现它们能降低死亡率或致残率。

Ann Intern Med:轻度原发性甲状旁腺功能亢进的死亡率和发病率

甲状旁腺切除术似乎不能降低轻度PHPT患者的发病率或死亡率。因此,在至少10年的时间里,该研究没有观察到与死亡、骨折、癌症、心脑血管事件或肾脏发病率相关的不良影响的证据。

JAMA Dermatol:全球2020年皮肤黑色素瘤的发病率和死亡率

黑色素瘤仍是全球癌症控制和公共卫生的一个重要挑战

Int J Biometeorol:述情障碍会提高皮肤疾病发病率

述情障碍(alexithymia)又译作“情感表达不能”或“情感难言症”,本文主要介绍述情障碍在皮肤科患者中的发病情况,进一步调查述情障碍对疾病负担、社会心理共病和治疗的影响。

A&R:影像学和症状性手部骨关节炎的患病率、发病率和进展

手部骨关节炎是一种异质性疾病,在年龄、性别、种族、手部症状和受影响的特定关节模式方面存在复杂的差异。有必要进一步研究调查这些差异背后的机制,无论是机械、代谢、荷尔蒙还是体质。

Lancet Gastroenterol Hepatol:过去30年全球结直肠癌的发病率和死亡率变化

在全球范围内,从1990年到2019年,结直肠癌病例增加了一倍以上

Baidu
map
Baidu
map
Baidu
map